European Journal of Pharmacology: Molecular Pharmacology
Volume 288, Issue 2, 16 January 1995, Pages 187-192
Regular paperInteraction of pristinamycin IA with P-glycoprotein in human intestinal epithelial cells
References (26)
- et al.
Evidence for a polarized efflux system for peptides in the apical membrane of Caco-2 cells
Biochem. Biophys. Res. Commun.
(1993) - et al.
P-glycoprotein possess a 1,4-dihydropyridine-selective drug acceptor site which is allosterically coupled to a vinca-lakaloid-selective binding site
Biochem. Biophys. Res. Commun.
(1992) - et al.
Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability
Gastroenterology
(1989) - et al.
Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells
J. Biol. Chem.
(1993) - et al.
Multidrug resistance during cancer chemotherapy: biotechnological solutions to a clinial problem
Trends Biotechnol.
(1993) - et al.
Peptide transport by the multidrug resistance pump
J. Biol. Chem.
(1992) - et al.
Azidopine noncompetitively interacts with visblatine and cyclosprotein A binding to P-glycoprotein in multidrug resistant cells
J. Biol. Chem.
(1991) - et al.
HT29-18-Cl intestinal cells: a ne model for studying the epithelial transport of drugs
Biochim. Biophys. Acta
(1993) - et al.
Polarized transport of decetaxel and viblastine mediated by P-glycoprotein in human intestinal epithelial cell monolayers
Biochem. Pharmacol.
(1994) Epithelial transport of drugs in cell culture. I: a model for studying the passive diffusion of drugs over absorbtive (Caco-2) cells
J. Pharm. Sci.
(1990)
Membrane vehicles from multidrug-resitant human cancer cells contain a specific 150 to 170-kDa protein detected by photoaffinity labeling
Virgiolamycin: nomenclature
J. Antibiotics
(1972)
Pharmacology of drugs that alter multidrug resistance in cancer
Pharmacol. Rev.
(1990)
Cited by (0)
Copyright © 1995 Published by Elsevier B.V.